Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Knowledge Acquisition, Self-Assessed Competence, and Simulator-Based Performance in a Structured Laparoscopic VR Curriculum for Obstetrics and Gynecology Residents: A Single-Center Observational Study.

Advances in medical education and practice·2026

Same author

Clinical Phenotype Comparison in Polish Patient Cohorts with and Without Molecular Diagnosis of Dystonia.

Journal of clinical medicine·2026

Same author

Integrating Mathematics into Prenatal Diagnosis-Different Phenotypes of Complex Ventral Wall Malformations Determined by Hierarchical Clustering.

Journal of clinical medicine·2026

Same author

Risk of meningomyelocele mediated by the common 22q11.2 deletion.

Science (New York, N.Y.)·2024

Same author

Coexisting Conditions Modifying Phenotypes of Patients with 22q11.2 Deletion Syndrome.

Genes·2023

Same author

Prenatal diagnosis of Emanuel syndrome - case series and review of the literature.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2022

Search research articles

Related Experiment Video

Updated: Oct 31, 2025

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

Extended genetic testing in fetuses with sonographic skeletal system abnormalities.

A Kucińska-Chahwan¹, T Roszkowski¹, B Nowakowska²

¹Department of Gynecology Oncology and Obstetrics, Centre of Postgraduate Medical Education, Warsaw, Poland.

Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology

|July 1, 2021

Summary

Extended genetic testing, including exome sequencing, significantly improves the diagnosis of skeletal system abnormalities in fetuses. This approach identifies genetic causes missed by standard chromosomal microarray analysis, aiding in comprehensive prenatal diagnosis.

Keywords:

exome sequencing prenatal diagnosis skeletal anomaly skeletal dysplasia ultrasound

More Related Videos

Murine Fetal Echocardiography

Murine Fetal Echocardiography

Published on: February 15, 2013

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Related Experiment Videos

Last Updated: Oct 31, 2025

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Published on: August 25, 2019

Murine Fetal Echocardiography

Murine Fetal Echocardiography

Published on: February 15, 2013

FISH for Pre-implantation Genetic Diagnosis

FISH for Pre-implantation Genetic Diagnosis

Published on: February 23, 2011

Area of Science:

Prenatal genetics
Fetal medicine
Medical diagnostics

Background:

Prenatal diagnosis of skeletal system abnormalities often requires detailed genetic analysis.
Standard genetic testing may not identify all underlying genetic causes of fetal skeletal defects.

Purpose of the Study:

To investigate the genetic causes of fetal skeletal abnormalities detected via prenatal sonography.
To establish an optimized diagnostic protocol using extended genetic testing for these cases.

Main Methods:

Prospective observational cohort study of singleton pregnancies with fetal skeletal abnormalities.
Utilized chromosomal microarray analysis (CMA) with polyploidy testing, followed by exome sequencing (ES) for non-diagnostic cases.
Expert panel reviewed variants to identify pathogenic/likely pathogenic mutations.

Main Results:

A total of 55 fetuses were analyzed; 43.6% had chromosomal abnormalities.
Exome sequencing (ES) increased the overall diagnostic yield by 32.7%, identifying pathogenic variants in 18 additional fetuses.
Overall, 76.4% of fetuses received an abnormal genetic test result, with variants found in 14 genes, including novel genes not typically associated with skeletal dysplasia.

Conclusions:

Chromosomal abnormalities are common genetic diagnoses in fetuses with skeletal anomalies.
Exome sequencing significantly enhances diagnostic yield beyond CMA and polyploidy testing.
Extended genetic testing is crucial for identifying genetic anomalies causing skeletal defects that might otherwise be missed.